Komori
Governance2784Alfresa Holdings CorporationTrading & Wholesale

Notice Regarding the Change in Subsidiary Status (Conversion of a Non-Consolidated Subsidiary into a Consolidated Subsidiary) and Management Structure

ArkMS, previously a non-consolidated subsidiary, will be included as a consolidated subsidiary from the first quarter of the fiscal year ending March 2027 because its qualitative materiality has increased. The organizational and officer structure as of 1 April 2026 is also presented.

Worth reading
52Recurring
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Controlling shareholder
Alfresa Holdings Corporation100.00%Voting rights

the Company), 100% (major shareholder and shareholding ratio

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Number of directors4 (of whom the number of outside directors is Not disclosed)
Changes this time

ArkMS, previously a non-consolidated subsidiary, will be included as a consolidated subsidiary from the first quarter of the fiscal year ending March 2027. The organizational and officer structure as of 1 April 2026 is described.

Governance structure
ItemDetails
Number of directors4 (of whom the number of outside directors is Not disclosed)
Controlling shareholderAlfresa Holdings Corporation (the Company), 100% (major shareholder and shareholding ratio)
Changes this timeArkMS, previously a non-consolidated subsidiary, will be included as a consolidated subsidiary from the first quarter of the fiscal year ending March 2027. The organizational and officer structure as of 1 April 2026 is described.
Items this document does not state (5)
Corporate Governance StructureNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defenses

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

ArkMS will provide increasingly extensive development support for pharmaceuticals and other products as a CRO, increasing its qualitative materiality in the consolidated financial statements. The group’s total supply chain services strategy is cited as the background.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Change in Subsidiary Status (Conversion of a Non-Consolidated Subsidiary into a Consolidated Subsidiary) and Management Structure | Alfresa Holdings Corporation (2784) timely disclosure | Komori